Sign Up | Log In | What is SocialPicks?

Auxilium Pharmaceuticals Inc. (AUXL) Trade Now » Rate AUXL - Discuss AUXL - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

92.5%

Top:

100.0%

Rate AUXL:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

AUXL Analysis & Videos »

... View All >

AUXL: Bull or Bear?

Rating: Positive Negative Neutral/Hold Auxilium Pharmaceuticals Inc. AUXL

62%

+15.72%
in 26 days

On 4/28/09, the FDA accepted for priority review (six-month) Auxilium's (NASDAQ:AUXL) BLA for Xiaflex (clostridial collagenase for injection) for the treatment of Dupuytren's contracture. AUXL filed the BLA on 2/27/09 and included data from 1,082 subjects and over 2,600 injections. The PDUFA decision date is 8/28/09 for the Xiaflex BLA. If approved by the FDA, AUXL plans to launch Xiaflex in the U.S. within 60 days during 2H09.

<> <> On 2/2/09, AUXL announced the completion of enrollment in a randomized, double-blind, placebo-controlled U.S. Phase 2b clinical trial for Xiafle...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 06/10/09

Comment

Updated Clinical Trial and FDA Decision Calendars AUXL

73%

+14.00%
in 124 days

Updated FDA and Clinical Trial Calendars

Posted by: Mike Havrilla in Untagged on Mar 04, 2009

<> Below are some recent updates to the BioMedReports.com -- FDA and Clinical Trial Calendars : <> 1.) Auxilium Pharma (AUXL): 3/2/09 BLA submission with priority review request for XIAFLEX (clostridial collagenase for injection), a novel, first-in-class, orphan-designated biologic for the treatment of Dupuytren's contracture. 5/2/09 is the date for FDA to accept the filing for review and decide on priority revi...

Continue reading »

By Mike Havrilla (+1.04% risk: conservative) 03/04/09

Comment

Fair Value on Auxilium Pharma AUXL

-16.75%
in 395 days

The fundamentals at Auxilium are solid, but the lofty valuation keeps us from recommending the name at this level.

Continue reading »

By Zacks.com (-19.77% risk: moderate) 06/05/08

Comment

The Name Brand Drug Revolution AUXL

50%

+2.01%
in 458 days

These guys are an in the midst of a major recovery.

I wish I would have had the chance to buy them while they were falling earlier in the year.

Medical is the only business without a market. Each medical IP stock has a virtual lock down on revenues for the length of life of the IP.

These guys are part of the new world order mental landscape painted in pigments and oil bases made of psychotropic chemical substances.

Continue reading »

By dcgfinancial (-10.53% risk: moderate) 04/03/08

Comment

... View All >

People Bullish on AUXL

Marian Filo

Principal

62%

26 days ago

Mike Havrilla

Principal

73%

4 mos ago

dcgfinancial

Sr. Analyst

50%

about 1 year ago

bluejetty

Sr. Analyst

21%

about 1 year ago

sodipodium

Analyst

37%

about 1 year ago

People Bearish on AUXL

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+43.39%	272
2	Gerald Greene	18.14	+59.31%	139
3	stockmarketfunding.com	17.66	+22.00%	34
4	akiralegrand	13.47	+15.91%	48
5	anup2104	12.13	+37.83%	12

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
GLD	streetTRACKS Gold
GS	Goldman Sachs Group Inc The
AMD	Advanced Micro Devices Inc
JPM	JPMorgan Chase & Co
FRE	Freddie Mac
GE	General Electric Company

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

PLX		BioMedReports: FDA Calendar Updates by Mike Havrilla
HX		Halifax Confident About Pushing Towards Profitibility by The GeoTeam
APPY		Extreme FDA Medical Device Trades: 7 Stocks Under $5 by Mike Havrilla
ARYX		Extreme FDA Calendar Trades: 18 Stocks Under $5 by Mike Havrilla
DGX		Quest Diagnostics Inc. by Marian Filo

... more »

StreetInsider.com on AUXL

Form 4 AUXILIUM PHARMACEUTICALS For: Jun 30 Filed by: CLASSON ROLF A

Form 4 ANIDO ARMANDO For: Jun 26

Form 4 AUXILIUM PHARMACEUTICALS For: Aug 22 Filed by: CREDIT SUISSE/

Form SC 13D/A AUXILIUM PHARMACEUTICALS Filed by: CREDIT SUISSE/

Auxilium Pharmaceuticals Selects Cegedim Dendrite SaaS CRM Solution

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Auxilium Pharmaceuticals Inc. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.